Financial Services

Private equity firm Brightstar brings on Davidson Kempner's Eric Epstein, signaling a major push to scale its platform and accelerate its AI ambitions.

Evolveum unveils midPilot, an AI to fix slow IGA onboarding, as firms flee proprietary tech for open-source control and digital sovereignty.

Industrial leader Modine joins the DOE's Better Plants program and earns key sustainability ratings, signaling a major strategic investment in efficiency.

ViewSonic launches a new subscription plan in Malaysia, shifting high-tech displays from a costly purchase to an affordable service for schools and businesses.

Parnell’s nixiFLOR, the first generic of Resflor Gold®, offers a cost-effective new weapon for ranchers battling Bovine Respiratory Disease.

The acquisition of the respected Christchurch firm marks Steele Raymond’s second in a year, signaling a major consolidation in the South Coast legal market.

AskBio completes enrollment for a pivotal Phase 2 trial of a one-time gene therapy, potentially revolutionizing treatment for millions with heart failure.

In its largest acquisition to date, Molex aims to dominate critical aerospace, medical, and AI markets by integrating Smiths Interconnect's portfolio.

For years, doctors dismissed her children's illness. One genetic test changed everything, revealing a truth hidden in their DNA and a flawed system.

Nodal Clear promotes Demetri Karousos to CEO and Huan Zhang to President, signaling a strategic focus on continuity, innovation, and risk management.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.

The energy services firm reports a 90% jump in adjusted EBITDA, crediting disciplined spending and a lucrative foray into the Alaskan snubbing market.

A scathing new report reveals systemic failures in federal Indigenous procurement, validating long-standing calls to end 'gilding' and phantom ventures.

A new $13.8M federal investment in BC's AI and aerospace sectors aims to bolster national security, meet NATO goals, and spur economic growth.

With a seasoned team and $253 million in fresh capital, Inflection Point's new SPAC signals strong investor confidence in a disciplined market.

With Stacy Walton as its first CCO, Longitude Rx signals a major push to disrupt specialty pharmacy and empower health systems against market headwinds.

Banking tech leader nCino posts record FY2026 results, fueling a major stock buyback and signaling deep confidence in its AI-driven global strategy.

Concord's new SVP of Sales, Andrew Coffey, brings deep operational experience, signaling a strategic shift to prioritize execution in a competitive market.

Investors eye Amerant Bancorp's Q1 results for signs of a turnaround after a challenging Q4 and a recent leadership change. Will its new strategy pay off?

A star-studded culinary gala raised over $1.75 million to support Illumination Health + Home's innovative model tackling homelessness in Orange County.